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A close relationship exists between the multiple systems in the 
body and the gradual exposure to the environmental influences of 
oxidative stress, such as airborne particulate matter, pesticides, diet 
and lifestyle. Over time, exposure to exogenous sources of oxida-
tive stress can ultimately impair both tissue and cellular function 
and  lead  to  cellular  senescence,  apoptosis,  and  the  destruction   
of  nuclear  chromatin.  The  effects  of  oxidative  stress  from  the   
environment  may  be  muted  in  some  individuals  if  sufficient 
anti-oxidant defenses are in place. However, in others, comprised 
defenses  such  as  those  that  can  occur  with  immune  system 
dysfunction,  can  lead  to  progressive  damage  in  genetic  coding 
and mitochondrial DNA that have been associated with signaling 
pathway  errors  and  tumorigenesis.  Interestingly,  “multiple  hits”   
by  environmental  toxins  may  be  required  to  lead  to  system   
dysfunction or tumor growth. For example, a number of studies 
have  observed  that  an  accumulation  of  gene  mutations  with 
increased  age  may  be  necessary  to  eventually  lead  to  cancers 
involving  the  breast  or  the  gastrointestinal  tract.  Furthermore, 
the exposure to exogenous agents that may generate the release of 
reactive oxygen species also may initiate a critical cascade of cell 
injury. The occurrence of genetic mutations from the initial release 
of reactive oxygen species can then lead to polymorphisms in key 
enzymes such as glutathione S-transferase and cytochrome p450 
that are vital to protect cells and tissues against oxidative stress.   
As  a  result  of  the  loss  of  these  anti-oxidant  pathways,  further 
accumulated tissue damage can ensue and the risk of developing 
significant illness increases further.
Given  the  intimate  relationship  between  the  body  and  its 
susceptibility  to  exogenous  sources  of  oxidative  stress,  we  have 
highlighted a number of novel studies in this issue of Oxidative 
Medicine and Cellular Longevity that examine specific cellular and 
tissue responses to endogenous agents and the broad anti-oxidant 
systems that can mitigate injury during normal physiology and 
disease states. Kovacic and Somanathan set the stage for this issue 
with their opinion paper that describes the biology of a halluci-
nogenic agent that was an integral part of religious ceremonies by 
early North American natives and its use remains in our current 
society, namely mescaline. Their work provides new understanding 
for  the  cellular  signaling  of  this  agent  in  the  nervous  system,   
its role in structure function relations, and its ties to the hallu-
cinogen  psilocybin.  In  his  review  article,  Flora  broadens  this 
perspective  in  regards  to  xenobiotics  with  metal  and  metalloid 
exposure. The biological properties of several agents that can lead 
to human illness are discussed that include copper, cobalt, and 
arsenic as well as the multiple anti-oxidant systems that can be 
activated,  such  as  carotenoids,  enzymes,  hormones,  phenolics, 
minerals,  and  vitamins.  Interestingly,  anti-oxidant  systems  also 
may play a significant role to prevent toxicity of chemotherapeutic 
agents.  Al-Yahya  et  al.  demonstrate  that  a  naturally  occurring 
branched-chain complex polysaccharide termed Gum Arabic can 
neutralize  acrolein,  a  reactive  metabolite  of  cyclophosphamide 
and block bladder toxicity from reactive oxygen species that may 
provide  new  direction  for  chemotherapeutic  agents  to  enhance   
efficacy  but  limit  toxicity.  The  ability  to  block  cellular  injury   
during  periods  of  toxic  elevated  reactive  oxygen  species  release 
also may be extended to a number systems throughout the body. 
Santo et al. show that ascorbic acid may be a powerful cytopro-
tectant in highly sensitive regions of the central nervous system 
during  epilepsy  and  oxidative  stress.  Furthermore,  in  the  paper 
by Mahapatra et al. that examines the effects of the exogenous   
toxin nicotine on immune cells, extracts from the plant Ocimum 
gratissimum  were  shown  to  have  high  flavonoid  and  phenolic 
content that may account for the ability of this agent to reduce 
super  oxide  anion  generation,  lipid  peroxidation,  and  prevent 
cytotoxicity  in  immune  cell  peritoneal  macrophages,  suggesting 
that even the inflammatory effects of tobacco smoke that contains 
at least sixty known carcinogens may be reduced with appropriate 
anti-oxidant  therapy.  The  efficacy  of  anti-oxidant  therapy  is   
brought to clinical consideration by Tripathi et al. in their paper. 
These  investigators  illustrate  that  administration  of  L-arginine, 
which has anti-apoptotic properties and can improve endothelial 
function, was able to lower serum cholesterol, increase superoxide 
dismutase  function,  and  enhance  the  levels  of  total  thiols  in 
patients  with  cardiac  ischemia,  suggesting  that  chronic  therapy 
with  L-arginine  in  these  patients  may  prevent  the  detrimental 
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effects of cardiac insufficiency. Work by Tang et al. adds further 
insight  into  the  role  of  tyrosine  phosphorylation  and  the  p75 
neurotrophin receptor during oxidative stress that may represent 
future therapeutic targets for disorders such as Alzheimer’s disease.
Knowledge  of  the  cellular  pathways  involved  during  clinical 
disease becomes a crucial point in an effort to develop effective 
clinical  therapeutics  since  presumed  cytoprotective  agents  when 
prospectively studied do not always prove to be useful or should 
be employed with caution. Work by Kingsley et al. brings this to 
light for us in their work that demonstrates that creatine, a popular 
“energy” supplement during exercise, is ineffective in attenuating 
oxidative stress during strenuous exercise regimens. As a result, the 
articles in this issue of Oxidative Medicine and Cellular Longevity 
offer new knowledge for the relationships that tie the environ-
ment, exogenous agents, and oxidative stress to multiple systems of 
the body. The studies illustrate for us that the use of therapeutics 
against  extended  stimulus  exposure  to  oxidative  stress  can  only 
effectively reduce an “oxidative deficit” through the identification 
of vital cellular pathways that ultimately control cell survival and 
longevity.
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